Target practice in severe asthma
Related Experiment Videos
1Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Science Translational Medicine
|March 31, 2017
Abstract:
The NLRP3 inflammasome/caspase-1/IL-1β axis may be a therapeutic target in severe steroid-resistant asthma.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dupilumab is associated with improved lung functions in patients with COPD and type 2 inflammation: a post hoc analysis of the BOREAS and NOTUS trials.
American journal of respiratory and critical care medicine·2026
Type 2 inflammation, bronchiectasis and clinical trials: expanding from MAHALE.
ERJ open research·2026
Allergen-responsive T helper type 2 cells revealed by high-dimensional profiling in allergen challenged human airways.
bioRxiv : the preprint server for biology·2026
Cross-cohort analysis of expression and splicing quantitative trait loci in TOPMed.
Science (New York, N.Y.)·2026
B cell subsets are associated with durable responses in distinct cancer types after immune checkpoint inhibition.
Science translational medicine·2026
Dengue virus controlled human challenge reveals that preexisting immunity shapes viral replication and broadly protective responses.
Science translational medicine·2026
Brain-sensing synNotch-CAR T cells enable precise targeting and clearance of diffuse midline glioma in multiple preclinical models.
Science translational medicine·2026
MIF-CD74 orchestrates synovial macrophage metabolic-inflammatory reprogramming by ENO2 interaction to drive osteoarthritis pathogenesis.
Science translational medicine·2026
Acute kidney injury as a systemic disease.
Science translational medicine·2026
A Large Multicenter Cohort of Ataxia-Telangiectasia: Clinical, Immunologic, Genetic, and Survival Outcomes.
European journal of neurology·2026
Glutamic acid decarboxylase (GAD)-65 antibodies-associated autoimmune neurological syndrome.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026